Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- Probable or possible transient ischemic attack
- Residing in Central Norway
- Examined within 2 weeks after the onset of symptoms
- Modified Rankin Scale 3 or less and living at home
- enrolled in the MIDNOR-TIA study NCT02038725
- Informed consent